For J&J OTC Sales, Tylenol Arthritis Label Approval Could Bring Relief Closer

FDA’s approval positions J&J/McNeil to return Tylenol 8HR Arthritis to the market with new packaging to interest consumers while also sustaining their connection with the iconic brand. The latest label design for the product features different color schemes and text fonts than the most recent previous changes.

More from United States

More from North America